Article
High levels of truncated RHAMM cooperate with dysfunctional p53 to accelerate the progression of pancreatic cancer
2021-02-20
Abstract excerpt
Pancreatic cancer has the lowest survival rate in all types of cancer. Pancreatic cancer patients are often diagnosed at advanced stages. A better therapeutic development for this devastating disease is urgently needed. Receptor for hyaluronan-mediated motility (RHAMM), not expressed in adult pancreas, has been suggested as a prognostic factor and a potential therapeutic target for pancreatic ductal adenocarcinoma...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 0ec2fc52-fe74-5c5f-b7d2-2a24ec0d284c
- DOI
- 10.1101/2021.02.19.432042
